Ubiquitination by HUWE1 in tumorigenesis and beyond

por Kao, Shih-Han, Wu, Han-Tsang, Wu, Kou-Juey
Publicado 2018

Nafamostat mesylate overcomes endocrine resistance of breast cancer through epigenetic regulation of CDK4 and CDK6 expression

por Lin, Yueh-Te, Lin, Joseph, Liu, Yi-En, Hsu, Kai-Wen, Hsieh, Chang-Chi, Chen, Dar-Ren, Wu, Han-Tsang
Publicado 2021

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1

por Lin, Yueh-Te, Lin, Joseph, Liu, Yi-En, Chen, Yun-Cen, Liu, Shiang-Ting, Hsu, Kai-Wen, Chen, Dar-Ren, Wu, Han-Tsang
Publicado 2022

RP11‐367G18.1 V2 enhances clear cell renal cell carcinoma progression via induction of epithelial–mesenchymal transition

por Shao, I‐Hung, Peng, Pei‐Hua, Wu, Heng‐Hsiung, Chen, Ji‐Lin, Lai, Joseph Chieh‐Yu, Chang, Jeng‐Shou, Wu, Han‐Tsang, Wu, Kou‐Juey, Pang, See‐Tong, Hsu, Kai‐Wen
Publicado 2023

K63-polyubiquitinated HAUSP deubiquitinates HIF-1α and dictates H3K56 acetylation promoting hypoxia-induced tumour progression

por Wu, Han-Tsang, Kuo, Yi-Chih, Hung, Jung-Jyh, Huang, Chi-Hung, Chen, Wei-Yi, Chou, Teh-Ying, Chen, Yeh, Chen, Yi-Ju, Chen, Yu-Ju, Cheng, Wei-Chung, Teng, Shu-Chun, Wu, Kou-Juey
Publicado 2016

Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis

por Peng, Pei-Hua, Chen, Ji-Lin, Wu, Heng-Hsiung, Yang, Wen-Hao, Lin, Li-Jie, Lai, Joseph Chieh-Yu, Chang, Jeng-Shou, Syu, Jia-Ling, Wu, Han-Tsang, Hsu, Fei-Ting, Cheng, Wei-Chung, Hsu, Kai-Wen
Publicado 2023